New Guidance and Forms for Consent for Systemic Anti-Cancer Therapy

The Chemotherapy Board, with support from Cancer Research UK, has published guidance on consent for Systemic Anti-Cancer Therapy (SACT). The guidance is accompanied by national SACT site – and regimen-specific consent forms. The guidance and forms – available on the Cancer Research UK website – are intended to support clinicians in ensuring that patients receiving SACT are fully informed when consenting to treatment. 

To view the new consent forms, click here.

Latest News

By BOPA Committee on 28th March 2024

UK Oncology Forum June 2024 – registration now open

Dear Colleagues Registration is now open for the 2024 UK Oncology Forum at DoubleTree by Hilton Brighton Metropole, Kings Rd, Brighton and Hove, Brighton BN1 2FU on Thursday 13th &…

Read article
By BOPA Committee on 28th March 2024

CRUK SACT Consent forms available for Acute Lymphoblastic Leukaemia (ALL)

Dear All, I am delighted to inform you that the Acute Lymphoblastic Leukaemia (ALL) SACT consent forms are now available on the CRUK website. The electronic consent guidance has also…

Read article
By BOPA Committee on 28th March 2024

Haematology Patient and Carers Congress (HPCC)

Dear BOPA Members, Please share with your patients, their families, carers, and colleagues…. A first ever, cross-disease site, Haematology Patient and Carers Congress (HPCC) 2024, is being held at the…

Read article
By BOPA on 20th March 2024

BSIO Annual Conference 2024

BSIO (British Society for Integrative Oncology) is the leading professional organisation for integrative oncology in the UK. Our goal is to promote the integration of evidence-informed conventional, nutritional, lifestyle and complementary…

Read article